Skip to main content
. Author manuscript; available in PMC: 2013 May 13.
Published in final edited form as: Eur J Pharm Biopharm. 2012 Sep 25;83(1):106–113. doi: 10.1016/j.ejpb.2012.09.005

Figure 2.

Figure 2

Effect of FXIIIa inhibitors on release of Staphylococcus aureus NCTC 8325 from human thrombi. A: Inhibitors R281 and R283. B: fluorescent inhibitor AM2/97.